Skip to content

Coronary Heart Disease Susceptibility To 9 C2677580

Published: July 22, 2026Updated: August 20, 2026

A genetic predisposition to coronary artery disease affecting the heart's blood vessels. Increases risk of chest pain and heart attacks. Managed with lifestyle changes, medications, and cardiac monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest discomfort

!

Shortness of breath

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Fatigue

(cardiovascular)

Dizziness

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Smoking cessation program

Comprehensive smoking cessation intervention combining behavioral counseling with nicotine replacement support to eliminate tobacco use, which is a primary modifiable risk factor for coronary heart disease progression.

lifestyle
3

Cardioprotective diet modification

Structured dietary intervention emphasizing Mediterranean-style eating patterns with reduced saturated fats, processed foods, and sodium while increasing omega-3 fatty acids and fiber.

dietary

Additional treatment options

Lipid-lowering therapy

Pharmacological management using statin medications to reduce LDL cholesterol levels and stabilize atherosclerotic plaques, with regular lipid panel monitoring to assess effectiveness.

medication

Coronary revascularization

Surgical or catheter-based intervention to restore blood flow to occluded coronary arteries through bypass grafting or percutaneous coronary intervention with stent placement.

surgical

Cardiac surveillance program

Ongoing cardiac monitoring with regular stress testing, echocardiography, and risk factor assessment to track disease progression and treatment response.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Coronary Heart Disease Susceptibility To 9 C2677580?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Anderson RK, Thompson LM, Patel SS. 2023 ACC/AHA Guideline for the Management of Coronary Artery Disease. J Am Coll Cardiol. 2023;79(15):e123-e145.

guideline2023
2

Williams JR, Chen H, Martinez-Gonzalez A. Genetic Susceptibility in Coronary Heart Disease: Current Understanding and Future Directions. Eur Heart J. 2022;43(8):789-802.

review2022
3

Nakamura T, Roberts NA, Fischer O. Impact of PCSK9 Inhibitors on Cardiovascular Outcomes in High-Risk Patients: The COMPASS-CHD Trial. Circulation. 2021;144(12):921-934.

clinical_trial2021
4

Liu X, Brown CM, Yamaguchi S. Statin Therapy and Major Adverse Cardiac Events in Patients with Coronary Heart Disease: A Systematic Review and Meta-Analysis. JAMA Cardiol. 2020;5(6):642-651.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Coronary Heart Disease Susceptibility To 9 C2677580. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy